BioNTech SE
+$0.17 (+0.11%) Today
$0.00 (0.00%) As of 8:31 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.
About BNTX
BioNTech SE engages in the development of novel medicines at the intersection of immunology and synthetic biology. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEO
Ugur Sahin
Employees
3,082
Headquarters
Mainz, Rheinland-Pfalz
Founded
2008
BNTX Key Statistics
Market cap
37.59B
Price-Earnings ratio
2.51
Dividend yield
0.60
Average volume
1.27M
High today
$157.88
Low today
$150.56
Open price
$154.20
Volume
671.06K
52 Week high
$464.00
52 Week low
$121.32
Analyst ratings
57%
of 14 ratings
Buy
42.9%
Hold
57.1%
Sell
0%
BNTX Earnings
-$1.03
$4.64
$10.30
$15.97
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Available Aug 8, Pre-Market